drugset / Trial / NCT03755089

Oral vs Intravesical Analgesia for Office Bladder Botox Injections

NCT03755089

Phase 4 Unknown 110 enrolled Women and Infants Hospital of Rhode Island
RandomizedParallel-groupOpen-labelTreatment

Summary

OnabotulinumtoxinA (Botox®) bladder injections are a highly effective treatment for overactive bladder and urgency urinary incontinence. The procedure is typically performed in the office setting with one of two medications to control comfort. However, the effectiveness of these medications has never been compared. The goal of this study is to determine which medication is better at providing comfort during bladder Botox® injections.

Timeline

Start
2018-11-01
Primary completion
2021-03-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 % Other
Comparator Lidocaine Other / unclassified 30 ml Other
Comparator Phenazopyridine Small molecule 200 mg Oral

Indications